Search research articles
Contact Us
Filters
Showing results (81-90 of 114) with videos related to
Page
of 12
Sort By:
Cancer Biotherapy & Radiopharmaceuticals
|
October 7, 2014
In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice
Panteleimon J Marsouvanidis, Marleen Melis, Erik de Blois, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 4, 2015
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT
Theodosia Maina, Hendrik Bergsma, Harshad R Kulkarni, et al.
FEMS Microbiology Ecology
|
June 19, 2018
Soils associated to different tree communities do not elicit predictable responses in lake bacterial community structure and function
Clara Ruiz-González, Esther Archambault, Isabelle Laforest-Lapointe, et al.
Journal of Medicinal Chemistry
|
March 9, 2018
New Gastrin Releasing Peptide Receptor-Directed [<sup>99m</sup>Tc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation
Berthold A Nock, David Charalambidis, Werner Sallegger, et al.
Pharmaceutics
|
March 28, 2024
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability
Xabier Guarrochena, Panagiotis Kanellopoulos, Anna Stingeder, et al.
EJNMMI Research
|
May 25, 2019
Instant kit preparation of <sup>68</sup>Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [<sup>68</sup>Ga]Ga-DATA-TOC
Jean-Philippe Sinnes, Johannes Nagel, Bradley P Waldron, et al.
Pharmaceutics
|
March 29, 2023
[<sup>111</sup>In]In/[<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>-LM4 SST<sub>2</sub>R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results
Berthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2016
Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
Berthold A Nock, Aikaterini Kaloudi, Emmanouil Lymperis, et al.
International Journal of Cancer
|
May 12, 2019
Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist <sup>177</sup> Lu-DOTAGA-PEG<sub>2</sub> -RM26
Bogdan Mitran, Sara S Rinne, Mark W Konijnenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 30, 2011
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607
Meltem Ocak, Anna Helbok, Christine Rangger, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 114) with videos related to
Sort By:
Page
of 12
Cancer Biotherapy & Radiopharmaceuticals
|
October 7, 2014
In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice
Panteleimon J Marsouvanidis, Marleen Melis, Erik de Blois, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 4, 2015
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT
Theodosia Maina, Hendrik Bergsma, Harshad R Kulkarni, et al.
FEMS Microbiology Ecology
|
June 19, 2018
Soils associated to different tree communities do not elicit predictable responses in lake bacterial community structure and function
Clara Ruiz-González, Esther Archambault, Isabelle Laforest-Lapointe, et al.
Journal of Medicinal Chemistry
|
March 9, 2018
New Gastrin Releasing Peptide Receptor-Directed [<sup>99m</sup>Tc]Demobesin 1 Mimics: Synthesis and Comparative Evaluation
Berthold A Nock, David Charalambidis, Werner Sallegger, et al.
Pharmaceutics
|
March 28, 2024
Amide-to-Triazole Switch in Somatostatin-14-Based Radioligands: Impact on Receptor Affinity and In Vivo Stability
Xabier Guarrochena, Panagiotis Kanellopoulos, Anna Stingeder, et al.
EJNMMI Research
|
May 25, 2019
Instant kit preparation of <sup>68</sup>Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [<sup>68</sup>Ga]Ga-DATA-TOC
Jean-Philippe Sinnes, Johannes Nagel, Bradley P Waldron, et al.
Pharmaceutics
|
March 29, 2023
[<sup>111</sup>In]In/[<sup>177</sup>Lu]Lu-AAZTA<sup>5</sup>-LM4 SST<sub>2</sub>R-Antagonists in Cancer Theranostics: From Preclinical Testing to First Patient Results
Berthold A Nock, Panagiotis Kanellopoulos, Euy Sung Moon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2016
Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
Berthold A Nock, Aikaterini Kaloudi, Emmanouil Lymperis, et al.
International Journal of Cancer
|
May 12, 2019
Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist <sup>177</sup> Lu-DOTAGA-PEG<sub>2</sub> -RM26
Bogdan Mitran, Sara S Rinne, Mark W Konijnenberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 30, 2011
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607
Meltem Ocak, Anna Helbok, Christine Rangger, et al.
Page
of 12